{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:59Z","timestamp":1759104179436,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["0720440"],"award-info":[{"award-number":["0720440"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004084","name":"Korea Science and Engineering Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["M1064152000108N415200110"],"award-info":[{"award-number":["M1064152000108N415200110"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancergeneticsjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.cancergencyto.2010.08.007","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T05:25:04Z","timestamp":1292304304000},"page":"193-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cytogenetic features of 5q deletion and 5q\u2212 syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization"],"prefix":"10.1016","volume":"203","author":[{"given":"Hye Ryun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bora","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Sik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Young","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwi-Joong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-A","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Sam","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Mee","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo-Min","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Kyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.08.007_bib1","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"87","article-title":"Myelodysplastic syndromes","author":"Brunning","year":"2008"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","article-title":"Cytogenetic features in myelodysplastic syndromes","volume":"87","author":"Haase","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib5","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-05-1437","article-title":"Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies","volume":"12","author":"Giagounidis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib7","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1182\/blood.V99.12.4638","article-title":"Narrowing and genomic annotation of the commonly deleted region of the 5q\u2212 syndrome","volume":"99","author":"Boultwood","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<251::AID-GCC11>3.0.CO;2-R","article-title":"Molecular cytogenetic delineation of the critical deleted region in the 5q\u2212 syndrome","volume":"22","author":"Jaju","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders","volume":"110","author":"Joslin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"},{"year":"2005","series-title":"ISCN (2005): an international system for human cytogenetic nomenclature","author":"Shaffer","key":"10.1016\/j.cancergencyto.2010.08.007_bib12"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","article-title":"Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients","volume":"24","author":"Germing","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib14","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood.V98.10.2935","article-title":"Myelodysplastic syndromes, from French\u2013American\u2013British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution","volume":"98","author":"Nosslinger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-4608(01)00533-7","article-title":"Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study","volume":"132","author":"Lee","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.thj.6200173","article-title":"The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution","volume":"3","author":"Zhao","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.leu.2402798","article-title":"Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome","volume":"17","author":"Lee","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.leu.2403806","article-title":"Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution","volume":"19","author":"Bernasconi","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2403688","article-title":"Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries","volume":"19","author":"Chen","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib20","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","article-title":"Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the U.S. with a focus on some undefined single chromosomal abnormalities","volume":"113","author":"Pozdnyakova","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2008.199","article-title":"Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan","volume":"22","author":"Tasaka","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.leukres.2003.11.001","article-title":"Factors influencing survival in myelodysplastic syndromes in\u00a0a Brazilian population: comparison of FAB and WHO classifications","volume":"28","author":"Lorand-Metze","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib23","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.leukres.2005.11.015","article-title":"Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients","volume":"30","author":"Navarro","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.leukres.2005.10.018","article-title":"Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications","volume":"30","author":"Irons","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0145-2126(94)00135-W","article-title":"Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare","volume":"19","author":"Oguma","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib27","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood-2002-03-0947","article-title":"Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia","volume":"101","author":"Matsushima","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2007.01.013","article-title":"Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome\u2013acute myeloid leukemia actually differ?","volume":"176","author":"Lessard","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib30","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.0610477104","article-title":"Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q\u2212 syndrome patients","volume":"104","author":"Pellagatti","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.leukres.2008.03.009","article-title":"International Working Group on MDS cytogenetics: October 2007 meeting report","volume":"32","author":"Slovak","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.cancergencyto.2010.08.007_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:49:33Z","timestamp":1759045773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0165460810004498"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.08.007","relation":{},"ISSN":["0165-4608"],"issn-type":[{"type":"print","value":"0165-4608"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic features of 5q deletion and 5q\u2212 syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics and Cytogenetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}